Mybiotech GmbH

Mybiotech GmbH is an SME in Uberherrn, Germany that has taken part in 25 EU-funded projects since 2017, receiving €10.5M in EU funding and leading 2 as coordinator.

EU funding received€10.5M
EU projects25
As coordinator2
Running now14
First EU project2017
Latest project2027
CountryGermany
EU registration (PIC)911296668
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Mybiotech GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€6.1M · 9 projects
  • Horizon Europe€4.4M · 15 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

25 EU-funded projects, newest first. Mybiotech GmbH led 2 of them as coordinator. Each links to the official record.

  • FAroGelsPartner

    Food-Grade Aerogels for Sustainable Food Systems

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €290ktheir share
  • Fix-AProPartner

    Fixing Alternative Proteins: Overcoming Key Challenges for Practical Integration into Food Systems

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €65ktheir share
  • IDEASPartner

    Improving Drug Efficacy with next-generation AmorphouS materials and trained experts

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €290ktheir share
  • INTROSCoordinator

    Towards Innovative Treatments and Management Of Surgical and Burn Wounds

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €290ktheir share
  • NExGliOPartner

    Nanoparticle-Assisted liquid biopsy based on Extracellular for Early Diagnosis of Glioblastoma

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €80ktheir share
  • BIOPHAMAssociated partner

    Bio and Pharmaceutical Materials Science

    Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗

  • APRISEPartner

    Alternative Proteins Research and Innovation Skills Enhancement

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €197ktheir share
  • VIVIDPartner

    Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €381ktheir share
  • GreenNanoBonePartner

    Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €487ktheir share
  • MEDiCSPartner

    Anticancer approach based on the Metabolic Disruption of Cancer Stem Cells with high effectivity across a wide range of solid tumours

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €773ktheir share
  • GreenX3Coordinator

    Innovative and sustainable materials, processes and technologies for a GREENer and circular economy

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €521ktheir share
  • TALENTSAssociated partner

    Training AlliancE for Novel Microbiome-Modulating TherapieS

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • NABIHEALPartner

    ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €353ktheir share
  • POTENTIALPartner

    Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €194ktheir share
  • MACRAMEPartner

    Advanced Characterisation Methodologies to assess and predict the Health and Environmental Risks of Advanced Materials

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €52ktheir share
  • ETERNALPartner

    Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €423ktheir share
  • CompSafeNanoPartner

    NanoInformatics Approaches for Safe-by-Design NanoMaterials

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €28ktheir share
  • PhoenixPartner

    Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €4.2Mtheir share
  • Bio2BrainPartner

    Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €253ktheir share
  • NanoCarbPartner

    Glyco-Nanoparticles for Applications in Advance Nanomedicine

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • NANOSTEMPartner

    New nanomaterials for neural stem cells drug delivery

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €249ktheir share
  • iFermenterPartner

    iFERMENTER - CONVERSION OF FORESTRY SUGAR RESIDUAL STREAMS TO ANTIMICROBIAL PROTEINS BY INTELLIGENT FERMENTATION

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €128ktheir share
  • nTRACKPartner

    Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €437ktheir share
  • npSCOPEPartner

    The nanoparticle-scope : a new integrated instrument for accurate and reproducible physico-chemical characterisation of nanoparticles (npSCOPE)

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €202ktheir share
  • N2B-patchPartner

    Nose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €559ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • antibiotic resistance
  • antibiotics
  • autoimmune diseases
  • big data
  • biochemistry
  • bioeconomy
  • biomass
  • biomaterials
  • bioreactors
  • breast cancer
  • carbohydrates
  • cells technologies
  • coating and films

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime